COVID-19 & Emerging Diseases

“When COVID-19 emerged, we realized that we had to pivot to quickly mobilize the resources needed in order to respond to the urgent calls for assistance that we were receiving.”

— Wafaa El-Sadr, ICAP Director

From the moment the first evidence of the coronavirus pandemic appeared in late 2019, ICAP at Columbia University recognized the potentially devastating impact of COVID-19 in many of the countries where it works, countries where health systems are particularly fragile. Building on nearly two decades of experience in responding to the world’s most significant public health challenges and harnessing its longstanding partnerships with ministries of health across the globe, ICAP mounted a comprehensive response to COVID-19 in 24 countries in Africa, Asia, and the Americas in partnership with stakeholders in each of the countries.

With tens of millions of dollars in funding raised through relentless efforts and a mandate to act quickly in the face of a dangerous and rapidly spreading disease, ICAP directed its teams and these resources to create firewalls of detection, prevention, and response to stand between the spreading virus and the communities in its path.

ICAP’s ongoing response to the continuing pandemic has spanned the gamut of public health activities, including:

  • Training of health workers
  • Standing up emergency operation centers
  • Establishing fever clinics and health brigades
  • Procuring personal protective and medical equipment
  • Identifying new prevention and treatment methods
  • Optimizing infection prevention and control
  • Supporting surveillance and conducting surveys

COVID-19 News

(FORTUNE) You Will Probably Get Omicron. It’s Time to Adjust Expectations About What Beating COVID Means

(Archived Webinar) ICAP Grand Rounds Webinar — The Cost of COVID-19: Understanding LGBTQ+ Experiences in New York City

(FORTUNE) Omicron Testing Shortages and Delays Are Making Results Useless—And Deepening COVID Inequality

(Korean Broadcasting System) In Omicron Emergency, Will the US Go Into Lockdown?

(AP NEWS) COVID Case Counts May Be Losing Importance Amid Omicron

(FORTUNE) End of the COVID Pandemic May Be in Sight, New Omicron Studies Suggest

(The Week) New York City’s New Year’s Eve Celebration in Times Square Going Forward

(New York Times) Adams’s Virus Policy Includes Keeping Vaccine Mandate for Businesses

(New York Times) What to Know About the Times Square Ball Drop on New Year’s Eve

(FORTUNE) FDA Says Antigen Rapid Covid Tests May Be Less Effective in Detecting Omicron Variant

(Gothamist) NYC Public Schools Will Reopen on Jan. 3 With Expanded Testing for Vaccinated and Unvaccinated Students, Staff

(NEWSWEEK) 400 People with COVID Mistakenly Told They Had Negative Test Results Before Christmas

COVID-19 Resources

Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impact

Special Webinar (Archived Recording) – The Impact of COVID-19 on the Opioid Crisis

Maintaining robust HIV and TB services in the COVID-19 era: A public health dilemma in Zimbabwe

Safeguarding gains in the Sexual and Reproductive Health and AIDS Response amidst COVID-19: The Role of African Civil Society

What One Pandemic Can Teach Us in Facing Another

Data-Driven HIV Programming to Maximize Health Benefits

COVID-19 Response in Zimbabwe: A Call for Urgent Scale-up of Testing to Meet National Capacity

Screening and Diagnosis of COVID-19 – A Training Toolkit

Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios

Special Webinar (Archived Recording) – Phylogeny and COVID-19: Shedding light on origin and transmission of SARS-CoV-2

Managing COVID-19 outbreak in Nigeria: matters arising

Antibody testing for coronavirus disease 2019: not ready for prime time